Cogstate Crecimiento futuro

Future controles de criterios 1/6

Se prevé que los beneficios de Cogstate disminuyan a un ritmo anual de 9.4%, mientras que sus ingresos anuales crecerán a un ritmo de 16.5% por año. Se espera que el BPA disminuya en un 8.2% al año.

Información clave

-9.4%

Tasa de crecimiento de los beneficios

-8.2%

Tasa de crecimiento del BPA

Crecimiento de los beneficios de Healthcare Services	25.9%
Tasa de crecimiento de los ingresos	16.5%
Rentabilidad financiera futura	n/a
Cobertura de analistas	Low
Última actualización	21 Mar 2024

Actualizaciones recientes sobre el crecimiento futuro

Recent updates

Growth Investors: Industry Analysts Just Upgraded Their Cogstate Limited (ASX:CGS) Revenue Forecasts By 11%

Mar 23

Earnings Update: Cogstate Limited (ASX:CGS) Just Reported And Analysts Are Trimming Their Forecasts

Mar 02

Cogstate Limited (ASX:CGS) Shares Could Be 19% Below Their Intrinsic Value Estimate

Jan 13

Investors Appear Satisfied With Cogstate Limited's (ASX:CGS) Prospects As Shares Rocket 51%

Oct 04

Do Cogstate's (ASX:CGS) Earnings Warrant Your Attention?

Sep 28

Returns On Capital Are A Standout For Cogstate (ASX:CGS)

Sep 02

We Ran A Stock Scan For Earnings Growth And Cogstate (ASX:CGS) Passed With Ease

Jun 30

Investors Should Be Encouraged By Cogstate's (ASX:CGS) Returns On Capital

Mar 22

We Think Some Shareholders May Hesitate To Increase Cogstate Limited's (ASX:CGS) CEO Compensation

Oct 20

Cogstate (ASX:CGS) Is Looking To Continue Growing Its Returns On Capital

Jul 23

Is Cogstate (ASX:CGS) Using Too Much Debt?

Apr 29

What Can The Trends At Cogstate (ASX:CGS) Tell Us About Their Returns?

Mar 14

Here's What Cogstate Limited's (ASX:CGS) Shareholder Ownership Structure Looks Like

Feb 21

How Much Is Cogstate's (ASX:CGS) CEO Getting Paid?

Jan 17

Can You Imagine How Jubilant Cogstate's (ASX:CGS) Shareholders Feel About Its 214% Share Price Gain?

Dec 05

Previsiones de crecimiento de beneficios e ingresos

ASX:CGS - Estimaciones futuras de los analistas y datos financieros pasados (USD Millions)
Fecha	Ingresos	Beneficios	Flujo de caja libre	Flujo de caja operativo	Núm. de analistas medio
6/30/2025	52	5	8	8	1
6/30/2024	42	4	1	1	1
12/31/2023	41	6	-1	0	N/A
9/30/2023	41	5	-1	1	N/A
6/30/2023	40	4	-2	1	N/A
3/31/2023	41	4	1	4	N/A
12/31/2022	41	3	4	8	N/A
9/30/2022	43	6	5	9	N/A
6/30/2022	45	8	6	10	N/A
3/31/2022	43	9	4	7	N/A
12/31/2021	42	10	2	4	N/A
9/30/2021	37	7	8	10	N/A
6/30/2021	33	5	13	16	N/A
3/31/2021	30	3	12	16	N/A
12/31/2020	28	0	11	15	N/A
9/30/2020	25	-1	4	8	N/A
6/30/2020	23	-2	-2	1	N/A
3/31/2020	21	-3	-3	0	N/A
12/31/2019	19	-3	-4	-2	N/A
9/30/2019	21	-3	-3	-1	N/A
6/30/2019	22	-2	-3	0	N/A
3/31/2019	24	-2	-2	1	N/A
12/31/2018	27	-1	-1	2	N/A
9/30/2018	28	-1	-2	1	N/A
6/30/2018	29	-1	-3	0	N/A
3/31/2018	27	-2	-4	-1	N/A
12/31/2017	26	-3	-4	-2	N/A
9/30/2017	26	-2	N/A	0	N/A
6/30/2017	26	-1	N/A	2	N/A
3/31/2017	26	0	N/A	3	N/A
12/31/2016	24	1	N/A	4	N/A
9/30/2016	23	1	N/A	3	N/A
6/30/2016	20	2	N/A	2	N/A
3/31/2016	19	1	N/A	1	N/A
12/31/2015	17	0	N/A	-1	N/A
9/30/2015	14	-2	N/A	-1	N/A
6/30/2015	12	-4	N/A	-2	N/A
3/31/2015	11	-3	N/A	-2	N/A
12/31/2014	10	-3	N/A	-2	N/A
9/30/2014	10	-3	N/A	-3	N/A
6/30/2014	11	-4	N/A	-3	N/A
3/31/2014	11	-4	N/A	-3	N/A
12/31/2013	11	-4	N/A	-3	N/A
9/30/2013	11	-3	N/A	-2	N/A
6/30/2013	11	-2	N/A	-1	N/A

Previsiones de crecimiento futuro de los analistas

Ingresos vs. Tasa de ahorro: Se prevé que los beneficios de CGS disminuyan en los próximos 3 años (-9.4% al año).

Beneficios vs. Mercado: Se prevé que los beneficios de CGS disminuyan en los próximos 3 años (-9.4% al año).

Beneficios de alto crecimiento: Se prevé que los beneficios de CGS disminuyan en los próximos 3 años.

Ingresos vs. Mercado: Se prevé que los ingresos (16.5% al año) de CGS crezcan más rápidamente que los del mercado Australian (4.7% al año).

Ingresos de alto crecimiento: Se prevé que los ingresos 16.5% al año) de CGS crezcan más despacio que 20% al año.

Previsiones de crecimiento de los beneficios por acción

Rentabilidad financiera futura

ROE futura: Datos insuficientes para determinar si la rentabilidad financiera de CGS se prevé que sea elevada dentro de 3 años.

Descubre empresas en crecimiento

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Cogstate Crecimiento futuro

Future controles de criterios 1/6

Información clave

Actualizaciones recientes sobre el crecimiento futuro

Price target decreased by 8.1% to AU$1.70

Price target increased by 8.6% to AU$1.85

Cogstate Limited Provides Revenue Guidance for 2024

Price target decreased by 9.0% to AU$1.70

Cogstate Limited Provides Revenue Guidance in the Fourth Quarter 2023

Consensus EPS estimates increase by 12%

Recent updates

First half 2024 earnings released: EPS: US$0.012 (vs US$0 in 1H 2023)

Price target decreased by 8.1% to AU$1.70

Investor sentiment deteriorates as stock falls 17%

The Price Is Right For Cogstate Limited (ASX:CGS)

Cogstate Limited to Report First Half, 2024 Results on Feb 22, 2024

Price target increased by 8.6% to AU$1.85

Cogstate Limited Provides Revenue Guidance for 2024

Full year 2023 earnings: EPS and revenues exceed analyst expectations

Is Cogstate Limited (ASX:CGS) Trading At A 29% Discount?

Now 21% undervalued

Price target decreased by 9.0% to AU$1.70

Now 23% undervalued

Cogstate Limited Provides Revenue Guidance in the Fourth Quarter 2023

Consensus EPS estimates increase by 12%

Returns Are Gaining Momentum At Cogstate (ASX:CGS)

Growth Investors: Industry Analysts Just Upgraded Their Cogstate Limited (ASX:CGS) Revenue Forecasts By 11%

Consensus revenue estimates increase by 11%

Investor sentiment deteriorates as stock falls 16%

CEO, MD & Executive Director recently bought AU$100k worth of stock

Earnings Update: Cogstate Limited (ASX:CGS) Just Reported And Analysts Are Trimming Their Forecasts

First half 2023 earnings released: EPS: US$0 (vs US$0.024 in 1H 2022)

Consensus EPS estimates increase by 23%, revenue downgraded

Investor sentiment deteriorates as stock falls 25%

Now 24% undervalued

Cogstate Limited to Report Fiscal Year 2023 Results on Aug 17, 2023

Now 22% undervalued

Cogstate Limited Announces Resignation of David Dolby as Non-Executive Director

Cogstate Limited (ASX:CGS) Shares Could Be 19% Below Their Intrinsic Value Estimate

Price target decreased to AU$1.92

High number of new and inexperienced directors

Investors Appear Satisfied With Cogstate Limited's (ASX:CGS) Prospects As Shares Rocket 51%

Do Cogstate's (ASX:CGS) Earnings Warrant Your Attention?

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Returns On Capital Are A Standout For Cogstate (ASX:CGS)

Price target decreased to AU$2.18

Full year 2022 earnings: EPS misses analyst expectations

Price target decreased to AU$2.41

Cogstate Limited Provides Earnings Guidance for the Fiscal Year 2023

High number of new and inexperienced directors

Price target decreased to AU$2.43

Investor sentiment improved over the past week

High number of new and inexperienced directors

We Ran A Stock Scan For Earnings Growth And Cogstate (ASX:CGS) Passed With Ease

Cogstate Announces Formation of Scientific Advisory Board

Consensus EPS estimates fall by 82%

Investor sentiment improved over the past week

Investors Should Be Encouraged By Cogstate's (ASX:CGS) Returns On Capital

First half 2022 earnings: Revenues and EPS in line with analyst expectations

Investor sentiment deteriorated over the past week

We Think Some Shareholders May Hesitate To Increase Cogstate Limited's (ASX:CGS) CEO Compensation

Independent Non-Executive Director exercised options to buy AU$244k worth of stock.

Non-Executive Chairman recently sold AU$89k worth of stock

Non-Executive Chairman exercised options and sold AU$188k worth of stock

Investor sentiment improved over the past week

Full year 2021 earnings released: EPS US$0.031 (vs US$0.008 loss in FY 2020)

Insider recently sold AU$1.8m worth of stock

Cogstate (ASX:CGS) Is Looking To Continue Growing Its Returns On Capital

Insider recently sold AU$1.3m worth of stock

Is Cogstate (ASX:CGS) Using Too Much Debt?

CEO, MD & Executive Director exercised options to buy AU$679k worth of stock.

What Can The Trends At Cogstate (ASX:CGS) Tell Us About Their Returns?

Cogstate Announces Company Secretary Changes

Here's What Cogstate Limited's (ASX:CGS) Shareholder Ownership Structure Looks Like

How Much Is Cogstate's (ASX:CGS) CEO Getting Paid?

Cogstate Limited to Report Q4, 2021 Results on Jul 28, 2021

Can You Imagine How Jubilant Cogstate's (ASX:CGS) Shareholders Feel About Its 214% Share Price Gain?

Cogstate Appoints Kim Wenn as Independent Non-Executive Director

New 90-day high: AU$1.29